Table 1 Main characteristics of studies included to meta-analysis.
From: Rethinking Alzheimer’s: novel miRNAs illuminate a disease beyond the brain
Study | Sample size (AD + CN) | miRNAs analyzed | Source | Expression analysis | Data |
|---|---|---|---|---|---|
Batabyal 2023 | 18 + 14 | 2578 | Serum | microArray | DE results |
Čarná 2023 | 9 + 11 | 2578 | Plasma | microArray | DE results |
Denk 2018 | 47 + 38 | 87 | Serum | RT-qPCR | Raw expression |
Dong 2015 | 127 + 123 (48 + 48 used) | 16 | Serum | RT-qPCR | DE results |
Dong 2021 | 8 + 8 | 1957 | Blood | RNAseq | Raw expression |
Fitz 2021 | 23 + 16 | 357 | Plasma | RNAseq | DE results |
Keller 2016 set 1 | 54 + 22 | 551 | Blood | RNAseq | DE results |
Keller 2016 set 2 | 49 + 55 | 494 | Blood | RNAseq | DE results |
Kumar 2017 | 10 + 14 | 68 | Serum | RT-qPCR | DE results |
Leidinger 2013 | 106 + 22 (48 AD used) | 366 | Blood | RNAseq | Raw expression |
Lu 2021 | 1021 + 288 | 2562 | Serum | microArray | DE results |
Ludwig 2019 | 145 + 214 | 21 | Blood | RT-qPCR | Raw expression |
Lugli 2015 | 35 + 35 | 463 | Plasma | RNAseq | Raw expression |
Palade 2024 | 33 + 71 | 299 | Plasma | RNAseq | DE results |
Nie 2020 | 5 + 20 | 100 | Plasma | RNAseq | Raw expression |
Shigemizu 2019 | 1021 + 288 | 2562 | Serum | microArray | Raw expression |
Visconte 2023 | 11 + 20 | 255 | Plasma | microArray | DE results |
Wang 2022 | 47 + 62 | 1957 | Plasma | RNAseq | DE results |
Wen 2024 | 28 + 21 | 786 | Serum | RNAseq | Raw expression |
Wu 2020 set 1 | 40 + 31 | 72 | Plasma | RNAseq | DE results |
Wu 2020 set 2 | 48 + 22 | 191 | Plasma | RNAseq | DE results |
Zhai 2024 | 6 + 6 | 2263 | Plasma | microArray | DE results |
